$64.78
-0.65[-0.99%]
Last update: 11:01AM Get Real Time Here
ANI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ANI Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | AM | ANIP | Q1 | $1.17 | $0.98 | — | — | $106.79M | $125.93M | — | — | Get Alert |
02/29/2024 | AM | ANIP | Q4 | $0.76 | $0.85 | $1.00 | 17.65% | $94.23M | $122.21M | $131.65M | 7.73% | Get Alert |
11/08/2023 | AM | ANIP | Q3 | $0.64 | $0.84 | $1.27 | 51.19% | $83.82M | $111.92M | $131.83M | 17.79% | Get Alert |
08/09/2023 | AM | ANIP | Q2 | $0.13 | $0.68 | $1.28 | 88.24% | $73.86M | $98.70M | $116.55M | 18.08% | Get Alert |
05/08/2023 | AM | ANIP | Q1 | -$0.12 | $0.35 | $1.17 | 234.29% | $64.48M | $83.49M | $106.79M | 27.90% | Get Alert |
03/09/2023 | AM | ANIP | Q4 | $0.54 | $0.67 | $0.76 | 13.43% | $60.93M | $86.14M | $94.23M | 9.39% | Get Alert |
11/09/2022 | AM | ANIP | Q3 | $1.01 | $0.55 | $0.64 | 16.36% | $52.06M | $78.16M | $83.82M | 7.24% | Get Alert |
08/08/2022 | AM | ANIP | Q2 | $0.67 | $0.22 | $0.13 | -40.91% | $48.63M | $72.10M | $73.86M | 2.43% | Get Alert |
05/10/2022 | AM | ANIP | Q1 | $1.04 | $0.09 | -$0.12 | -233.33% | $54.52M | $65.03M | $64.48M | -0.85% | Get Alert |
03/15/2022 | AM | ANIP | Q4 | $0.80 | $0.74 | $0.54 | -27.03% | $57.25M | $56.30M | $60.93M | 8.22% | Get Alert |
11/01/2021 | AM | ANIP | Q3 | $0.97 | $0.70 | $1.01 | 44.29% | $52.98M | $49.70M | $52.06M | 4.75% | Get Alert |
08/06/2021 | AM | ANIP | Q2 | $0.69 | $0.68 | $0.67 | -1.47% | $48.47M | $48.05M | $48.63M | 1.20% | Get Alert |
05/07/2021 | AM | ANIP | Q1 | $1.04 | $0.71 | $1.04 | 46.48% | $49.77M | $46.80M | $54.52M | 16.50% | Get Alert |
03/09/2021 | AM | ANIP | Q4 | $1.08 | $0.94 | $0.80 | -14.89% | $47.97M | $54.27M | $57.25M | 5.49% | Get Alert |
11/05/2020 | AM | ANIP | Q3 | $1.23 | $0.88 | $0.97 | 10.23% | $51.34M | $51.50M | $52.98M | 2.87% | Get Alert |
08/06/2020 | AM | ANIP | Q2 | $1.44 | $1.00 | $0.69 | -31.00% | $54.36M | $48.93M | $48.47M | -0.94% | Get Alert |
05/07/2020 | AM | ANIP | Q1 | $1.30 | $0.89 | $1.04 | 16.85% | $52.89M | $50.23M | $49.77M | -0.91% | Get Alert |
02/27/2020 | AM | ANIP | Q4 | $1.32 | $1.18 | $1.08 | -8.47% | $57.12M | $51.63M | $47.97M | -7.10% | Get Alert |
11/06/2019 | AM | ANIP | Q3 | $1.29 | — | $1.23 | — | $50.70M | — | $51.34M | — | Get Alert |
ANI Pharmaceuticals (ANIP) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $1.00, which beat the estimate of $0.85.
The Actual Revenue was $131.7M, which beat the estimate of $122.2M.
Browse earnings estimates, EPS, and revenue on all stocks.